Loyalty and rebate programs from toxin and filler manufacturers are a material line item in practice economics. AbbVie's Allē, Galderma's Aspire, and Evolus's Rewards program each operate on different mechanics, payout structures, and exclusivity rules. Understanding the real per-unit or per-syringe value—and the compliance and operational constraints—separates practices that optimize rebate capture from those leaving money on the table. This page walks through the architecture of each program, how to model their actual contribution to margin, and the hard limits on stacking.